The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
As dealmaking momentum continues in the healthcare sector globally, PwC released a report forecasting that M&A activity will remain at record levels through the second half of 2026. According to Seeking Alpha, the report highlights that the sector is benefiting from structural factors including the need for innovation and expansion of healthcare services. This outlook comes amid a wave of major transactions in the industry.
The PwC report comes at a time when global M&A activity is rebounding, with investors focusing on growth sectors like healthcare. Data shows the healthcare sector has been among the most active in dealmaking in recent months, with increasing interest in health-tech and pharmaceutical companies.
Investors are watching for upcoming deal announcements in the sector, especially as healthcare companies face pressure to enhance efficiency and drive growth. Upcoming quarterly reports from major players may provide further clues about the growth trajectory, amid expectations of continued capital flows into structural deals.
Sign in to access this content
Sign In